Sign in

CIK 0001570562 · Accelerated filer

Evolus, Inc.

Sign in to watch
Ticker
EOLS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
461385614
Phone
(949) 284-4555
Business address
520 NEWPORT CENTER DRIVE, SUITE 1200, NEWPORT BEACH, CA, 92660
Former names
Evolus, Inc.
  1. 8-K Event Results of operations
  2. 4 Planned sale See Remarks sold 10,539 shares at $7.15 ($75,361)
  3. 4 Planned sale See Remarks sold 2,261 shares at $7.15 ($16,168)
  4. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  5. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  6. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  7. 10-Q Report Quarterly Report
  8. 8-K Event Results of operations
  9. 4 Grant or award Chief Financial Officer acquired 104,603 shares (grant or award)
  10. 3 Insider Initial Statement of Ownership
  11. 8-K Event Executive or director change · Regulation FD disclosure
  12. 4 Planned sale Chief Marketing Officer sold 5,722 shares at $7.51 ($42,972)
  13. 4 Open-market buy Director bought 30,000 shares at $6.82 ($204,486)
  14. SCHEDULE 13G Stake Statement of Beneficial Ownership
  15. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  16. SCHEDULE 13G Stake Statement of Beneficial Ownership
  17. 10-Q Report Quarterly Report
  18. 8-K Event Results of operations · Executive or director change
  19. 4 Open-market sale See Remarks sold 127,905 shares at an average $10.03 ($1,283,195)
  20. 144 Insider Sale of Securities

Page 3 of 28 · 558 filings